| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 6, 2026 | Sell(S) | 8K | $28.04 | $235K | 260K |
| May 6, 2026 | Sell(S) | 16K | $29.13 | $478K | 243K |
| May 5, 2026 | Sell(S) | 10K | $28.12 | $285K | 269K |
| May 5, 2026 | Sell(S) | 963 | $29.00 | $28K | 268K |
| May 4, 2026 | Sell(S) | 9K | $27.50 | $254K | 286K |
| May 4, 2026 | Sell(S) | 6K | $28.37 | $157K | 280K |
| May 4, 2026 | Sell(S) | 320 | $29.56 | $9K | 280K |
| May 4, 2026 | Sell(S) | 705 | $30.08 | $21K | 279K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001728746-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for MapLight Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.